Should you pause aspirin before a colonoscopy?
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares stopping aspirin versus continuing it before a colonoscopy in people who take aspirin to prevent heart problems. The goal is to find out which approach is safer and works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You take aspirin every day (at least 80 mg) to lower your risk of heart attack or stroke.
- You are scheduled for a colonoscopy to screen for colorectal cancer.
- You have not had a heart stent placed in the last 6 months.
- You have not had a heart attack or stroke in the last 3 months.
- You are not taking blood thinners (like warfarin) or other antiplatelet drugs (like clopidogrel).
- You do not have a bleeding disorder (e.g., hemophilia) or liver disease that causes bleeding problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients who are already taking blood-thinning medicines and are scheduled for a planned colonoscopy. It may help improve how colonoscopies are done safely for people on these medicines.
This trial checks if it is safe to stop taking daily aspirin after a heart attack and a stent procedure, compared to continuing it. It aims to help older adults avoid unnecessary bleeding while preventing another heart attack or stroke.
This trial tests whether older adults with stable heart disease can safely stop taking daily aspirin after two years without increasing the risk of heart attack or stroke. It may help reduce the side effects of long-term aspirin use.
This study compares two different daily doses of aspirin (50 mg vs 100 mg) when taken with a standard blood thinner (P2Y12 inhibitor) after getting a heart stent. It aims to see if a lower aspirin dose works just as well with fewer side effects.
This Phase 2 trial studies how aspirin affects specific “biomarkers” (measurable body signals) in people newly diagnosed with colon or rectal cancer. The goal is to see whether aspirin-related changes can help design more personalized prevention treatment plans.
This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.
Hear when a new Cardiovascular Events trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.